The introduction of a generic version of the life-saving — and expensive — EpiPen was heralded as a long overdue fix. But the move is now causing some insurance companies to change how they approach ... read more
We use cookies to ensure that we give you the best experience on our website. Continuing to use this site assumes you accept the use of cookies. OkPrivacy Policy